More articles from Editorials

Nonpharmacological interventions in COPD
Wim Janssens, Geert M. Verleden

European Respiratory Review Mar 2023, 32 (167) 230028; DOI: 10.1183/16000617.0028-2023
The flare of care for rare: per aspera ad astra for rare lung diseases!
Marlies Wijsenbeek, Marc Humbert, Thomas Wagner, Michael Kreuter

European Respiratory Review Mar 2023, 32 (167) 230006; DOI: 10.1183/16000617.0006-2023
Respiratory infections
Michael S. Niederman, Antoni Torres

European Respiratory Review Dec 2022, 31 (166) 220150; DOI: 10.1183/16000617.0150-2022
Some take-home messages from the 9th International Meeting on Pulmonary Rare Diseases and Orphan Drugs
Sergio Harari, Yochai Adir, Marc Humbert

European Respiratory Review Dec 2021, 30 (162) 210258; DOI: 10.1183/16000617.0258-2021
Sex and gender in lung health and disease: more than just Xs and Ys
Jason Weatherald, Renata L. Riha, Marc Humbert

European Respiratory Review Dec 2021, 30 (162) 210217; DOI: 10.1183/16000617.0217-2021
Chronic hypersensitivity pneumonitis; an enigmatic and frequently fatal disease
Toby M. Maher

European Respiratory Review Jun 2020, 29 (156) 200177; DOI: 10.1183/16000617.0177-2020
Ultra-rare disease: an European perspective
Sergio Harari, Marc Humbert

European Respiratory Review Jun 2020, 29 (156) 200195; DOI: 10.1183/16000617.0195-2020
The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting?
Jeroen N. Wessels, Frances S. de Man, Anton Vonk Noordegraaf

European Respiratory Review Jun 2020, 29 (156) 200139; DOI: 10.1183/16000617.0139-2020
Desquamative interstitial pneumonia: still orphan and not always benign
Vincent Cottin

European Respiratory Review Jun 2020, 29 (156) 200183; DOI: 10.1183/16000617.0183-2020
Interventional pulmonology: between ambition and wisdom
Hervé Dutau, David Feller-Kopman

European Respiratory Review Jun 2020, 29 (156) 200146; DOI: 10.1183/16000617.0146-2020

Main menu

User menu

Search

More articles from Editorials

Pages

Contact us